| Autoregulation of cerebral blood flow in patients resuscitated from cardiac arrest C Sundgreen, FS Larsen, TM Herzog, GM Knudsen, S Boesgaard, ... Stroke 32 (1), 128-132, 2001 | 486 | 2001 |
| Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency R Rodrigues, M Artieda, D Tejedor, A Martínez, P Konstantinova, H Petry, ... Journal of clinical lipidology 10 (2), 394-409, 2016 | 49 | 2016 |
| Pharmaceutical compositions comprising desglymidodrine as an active drug substance C Sundgreen, A Schultz, J Schlyter, PM Olsen US Patent App. 09/864,857, 2002 | 35 | 2002 |
| Anti‐hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats BH Bentzen, M Grunnet, L Hyveled‐Nielsen, C Sundgreen, JB Lassen, ... Obesity 21 (5), 985-992, 2013 | 21 | 2013 |
| Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience MG Lindholm, J Aldershvile, C Sundgreen, E Jørgensen, K Saunamäki, ... European Journal of Heart Failure 5 (1), 73-79, 2003 | 17 | 2003 |
| Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial PM Machado, MP McDermott, T Blaettler, C Sundgreen, AA Amato, ... The Lancet Neurology 22 (10), 900-911, 2023 | 10 | 2023 |
| Pharmaceutical compositions for combination therapy HB Hansen, M Grunnet, BH Bentzen, L Hyveled-Nielsen, JB Lassen, ... US Patent 9,211,271, 2015 | 9 | 2015 |
| Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial M Benatar, T Hansen, D Rom, MA Geist, T Blaettler, W Camu, ... The Lancet Neurology 23 (7), 687-699, 2024 | 3 | 2024 |
| A randomized, double-blind, placebo-controlled study of arimoclomol in patients with inclusion body myositis (S23. 010) P Machado, R Barohn, M McDermott, T Blaetter, T Lloyd, A Shaibani, ... Neurology 98 (18_supplement), 969, 2022 | 3 | 2022 |
| P. 02Phase 2/3 study of Arimoclomol in sporadic inclusion body myositis: study design P Machado, R Barohn, M McDermott, T Blaetter, T Lloyd, A Shaibani, ... Neuromuscular Disorders 29, S41-S42, 2019 | 3 | 2019 |
| Pharmaceutical compositions for combination therapy HB Hansen, M Grunnet, BH Bentzen, L Hyveled-Nielsen, JB Lassen, ... US Patent 9,387,184, 2016 | 3 | 2016 |
| A randomized, double-blind, placebo-controlled study of arimoclomol in patients with inclusion body myositis PM Machado, RJ Barohn, M McDermott, T Blaetter, T Lloyd, A Shaibani, ... ANNALS OF NEUROLOGY 90, S223-S224, 2021 | 2 | 2021 |
| The early history of arimoclomol for inclusion body myositis M Dimachkie, P Machado, C Sundgreen, T Blaettler, J Statland, A Heim, ... RRNMF Neuromuscular Journal 2 (2), 62-70, 2021 | 1 | 2021 |
| Design of the phase 3, randomised, placebo-controlled trial of oral arimoclomol in amyotrophic lateral sclerosis ORARIALS-01 C Sundgreen, T Blaettler, R Bennett, D Rom, J Wuu, PM Andersen, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20, 271-272, 2019 | 1 | 2019 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ARIMOCLOMOL IN PATIENTS WITH INCLUSION BODY MYOSITIS PM Machado, RJ Barohn, M McDermott, T Blaettler, T Lloyd, A Shaibani, ... CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 41 (2), 417-417, 2023 | | 2023 |
| Reduction of oxidized phospholipids or misfolded protein aggregates by AAV-VecTabs in an Amyotrophic Lateral Sclerosis pre-clinical models M Sogorb-Gonzalez, S Pasteuning, W Pos, C Sundgreen, M Spits, ... MUSCLE & NERVE 66, S6-S6, 2022 | | 2022 |
| Pharmaceutical Compositions For Combination Therapy HB Hansen, M Grunnet, BH Bentzen, L Hyveled-Nielsen, JB Lassen, ... US Patent App. 17/386,098, 2022 | | 2022 |
| Pharmaceuticals for combination therapy L Hyveled-Nielsen, C Sundgreen, HB Hansen, BH Bentzen, M Grunnet, ... | | 2019 |
| Farmacinės kompozicijos, skirtos derinių terapijai HB HANSEN, M Grunnet, BH BENTZEN, L HYVELED-NIELSEN, ... | | 2019 |
| Pharmaceutical compositions for combination therapy HB Hansen, M Grunnet, BH Bentzen, L Hyveled-Nielsen, JB Lassen, ... US Patent App. 15/906,350, 2018 | | 2018 |
Gitte Moos KnudsenRigshospitalet & University of Copenhagen在 nru.dk 的电子邮件经过验证
